Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[306 Pages Report] The global colorectal cancer molecular diagnostics market garnered a market value of US$ 2.35 Billion in 2022 and is expected to accumulate a market value of US$ 5.07 Billion by registering a CAGR of 8% in the assessment period 2022-2032. Growth of the market can be attributed to increasing cases of cancer along with development in diagnostic laboratories.
Report Attribute | Details |
---|---|
Estimated Base Year Value (2021) | US$ 2.17 Billion |
Expected Market Value (2022) | US$ 2.35 Billion |
Anticipated Forecast Value (2032) | US$ 5.07 Billion |
Projected Growth Rate (2022 to 2032) | 8% CAGR |
Approximately 1.4 million new cases of colorectal cancer are diagnosed each year. Obtaining an early diagnosis is critical as it is currently one of the deadliest cancers, totalling more than 600,000 deaths each year.
Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor in personalized medicine. This, in turn, is increasing the dependency on colorectal cancer molecular diagnostics.
Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.
Positive market trends and increasing investor confidence in several key players are helping mergers and acquisition activities in the colorectal cancer molecular diagnostics market. The disruption in the global healthcare market due to political factors such as the Obama Care Act, and regulatory framework changes, and other trade barriers, are anticipated to trigger merger and acquisition activities to drive the colorectal cancer molecular diagnostics market consolidation and further intensify the market competition.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increase in research in the pharmaceutical and biotechnology industry is contributing to the growth of the colorectal cancer molecular diagnostics market significantly. In addition, growing automation in laboratories is another factor supporting the growth of the colorectal cancer molecular diagnostics market.
Moreover, the ease of use of colorectal cancer molecular diagnostics, as well as accurate results is supporting the growth of the colorectal cancer molecular diagnostics market. All these factors are increasing the use of colorectal cancer molecular diagnostics.
Despite colorectal cancer being common across the globe, many people do not get themselves tested at an early stage. This is owing to the lack of knowledge regarding the problem and its lasting effects on health. In addition, the availability of low-cost alternatives and the high cost of instruments may hinder the growth of the market during the forecast period.
Limited specificity to some diagnostics tests that are unable to distinguish between inflammation and actual symptoms or cancer is another issue being faced by the colorectal cancer molecular diagnostics market.
American Cancer Society states that 52,580 deaths are expected to occur due to colorectal cancer in 2022 in U.S. the number of people being diagnosed with colorectal cancer is increasing owing to habits such as smoking, drastic diet changes and stress. Moreover, people suffering from hereditary cancer diseases are likely to suffer from cancer in the region. As the awareness regarding getting diagnosed is increasing, more people have shown an inclination to undergo tests. Furthermore, owing to the increasing automation of labs in the region is positively Inflcuening the growth of the market.
Thus, North America is expected to hold the maximum market share and is expected to register a CAGR of 9% for the global colorectal cancer molecular diagnostics market.
The strong and evolving government support towards research in biotechnology and pharmaceutical industry in Asia Pacific especially in countries like India and China are contributing to the growth of colorectal cancer molecular diagnostics. Reports state that the number of people suffering from colorectal cancer are expected to increase by 2035, especially in India.
Thus, the government of the country is taking measures to spread awareness amongst people to get tested at an early stage. The Asia Pacific colorectal cancer molecular diagnostics market is anticipated to grow at a rapid pace with a maximum CAGR of more than 8% over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players in the global Colorectal Cancer Molecular Diagnostics market are Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Guardant Health, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation. Attributed to the presence of such high number of participants, the market is highly competitive.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 8% from 2022 to 2032 |
Market Value in 2022 | US$ 2.35 Billion |
Market Value in 2032 | US$ 5.07 Billion |
Base Year for Estimation | 2021 |
Historical Data | 2017 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Colorectal Cancer Molecular Diagnostic Instruments 5.3.2. Colorectal Cancer Molecular Diagnostic Reagents & Kits 5.3.3. Services 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032 6.3.1. PCR 6.3.2. Sequencing 6.3.3. Mass Spectrometry 6.3.4. Transcription Mediated Amplification 6.3.5. Chips and Microarrays 6.3.6. Isothermal Nucleic Acid Amplification Technology 6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021 6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032 7. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Diagnostic Laboratories 7.3.4. Homecare Settings 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 8. Global Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Technology 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Technology 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Technology 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Technology 10.3.4. By End User 10.4. Key Takeaways 11. Europe Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Technology 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Technology 11.3.4. By End User 11.4. Key Takeaways 12. East Asia Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product Type 12.2.3. By Technology 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Technology 12.3.4. By End User 12.4. Key Takeaways 13. South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Product Type 13.2.3. By Technology 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Technology 13.3.4. By End User 13.4. Key Takeaways 14. MEA Colorectal Cancer Molecular Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of MEA 14.2.2. By Product Type 14.2.3. By Technology 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Technology 14.3.4. By End User 14.4. Key Takeaways 15. Key Countries Colorectal Cancer Molecular Diagnostics Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Product Type 15.1.2.2. By Technology 15.1.2.3. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Product Type 15.2.2.2. By Technology 15.2.2.3. By End User 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Product Type 15.3.2.2. By Technology 15.3.2.3. By End User 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Product Type 15.4.2.2. By Technology 15.4.2.3. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Product Type 15.5.2.2. By Technology 15.5.2.3. By End User 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Product Type 15.6.2.2. By Technology 15.6.2.3. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Product Type 15.7.2.2. By Technology 15.7.2.3. By End User 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Product Type 15.8.2.2. By Technology 15.8.2.3. By End User 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Product Type 15.9.2.2. By Technology 15.9.2.3. By End User 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Product Type 15.10.2.2. By Technology 15.10.2.3. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Product Type 15.11.2.2. By Technology 15.11.2.3. By End User 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Product Type 15.12.2.2. By Technology 15.12.2.3. By End User 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Product Type 15.13.2.2. By Technology 15.13.2.3. By End User 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Product Type 15.14.2.2. By Technology 15.14.2.3. By End User 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Product Type 15.15.2.2. By Technology 15.15.2.3. By End User 15.16. ASEAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Product Type 15.16.2.2. By Technology 15.16.2.3. By End User 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Product Type 15.17.2.2. By Technology 15.17.2.3. By End User 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Product Type 15.18.2.2. By Technology 15.18.2.3. By End User 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Product Type 15.19.2.2. By Technology 15.19.2.3. By End User 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Product Type 15.20.2.2. By Technology 15.20.2.3. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product Type 16.3.3. By Technology 16.3.4. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Agilent Technologies 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Hologic 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Cepheid 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Qiagen 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Roche Diagnostics 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Bayer Healthcare 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Abbott Laboratories 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Grifols 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Danaher Corporation 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Siemens 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Beckton Dickinson 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. Biomérieux Sa 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Sysmex Corporation 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 5: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 6: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 7: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 8: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 9: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 10: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 11: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 12: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 13: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 14: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 15: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 16: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 17: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 18: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 19: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 20: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 21: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 23: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 24: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 25: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 26: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 27: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032 Table 28: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Figure 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Region, 2022-2032 Figure 5: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 6: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 7: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 8: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 9: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 10: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 11: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 12: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 13: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 14: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 15: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 16: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 17: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 18: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 19: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 20: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Region, 2022-2032 Figure 21: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 22: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 23: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 24: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 25: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 26: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 27: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 28: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 29: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 30: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 31: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 32: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 33: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 34: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 35: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 36: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 37: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 38: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 39: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 40: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032 Figure 41: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 42: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 43: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 44: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 45: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 46: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 47: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 48: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 49: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 50: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 51: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 52: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 53: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 54: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 55: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 56: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 57: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 58: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 59: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 60: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032 Figure 61: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 62: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 63: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 64: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 65: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 66: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 67: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 68: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 69: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 70: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 71: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 72: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 73: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 74: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 75: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 76: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 77: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 78: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 79: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 80: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032 Figure 81: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 82: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 83: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 84: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 85: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 86: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 87: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 88: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 89: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 90: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 91: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 92: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 93: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 94: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 95: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 96: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 97: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 98: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 99: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 100: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032 Figure 101: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 102: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 103: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 104: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 105: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 106: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 107: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 108: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 109: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 110: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 111: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 112: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 113: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 114: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 115: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 116: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 117: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 118: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 119: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 120: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032 Figure 121: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032 Figure 122: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032 Figure 123: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032 Figure 124: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032 Figure 125: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 126: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 127: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 128: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 129: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 130: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 131: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032 Figure 132: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032 Figure 133: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032 Figure 134: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 135: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 136: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 137: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032 Figure 138: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032 Figure 139: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032 Figure 140: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports